AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $72,000 | +148.3% | 11,139 | +52.0% | 0.00% | – |
| Q3 2019 | $29,000 | -19.4% | 7,326 | -1.0% | 0.00% | – |
| Q2 2019 | $36,000 | -41.0% | 7,400 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $61,000 | +13.0% | 7,400 | -25.4% | 0.00% | 0.0% |
| Q4 2018 | $54,000 | +1700.0% | 9,919 | +3206.3% | 0.00% | – |
| Q3 2018 | $3,000 | -57.1% | 300 | -54.3% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 657 | -1.2% | 0.00% | – |
| Q1 2018 | $6,000 | -40.0% | 665 | -0.2% | 0.00% | – |
| Q4 2017 | $10,000 | -23.1% | 666 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | +85.7% | 666 | +25.0% | 0.00% | – |
| Q2 2017 | $7,000 | +250.0% | 533 | +96.7% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 271 | -5.6% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 287 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 287 | +51.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |